It has been proved in animal models that CO might inhibit the activation of T cells in systematic lupus erythematosus (SLE) [42], and alleviate the inflammatory effect of peripheral mononuclear cell-derived MPO in vessels [43, 44]. Here, MPO is linked to systemic lupus erythematosus.